Radiotherapy compliance is maintained with hyprofractionation and concurrent cetuximab in locally advanced head and neck cancer

被引:8
|
作者
Chan, Andrew [1 ]
Teoh, Daien [1 ]
Singhera, Paul [1 ]
Hartley, Andrew [1 ]
机构
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
关键词
SQUAMOUS-CELL CARCINOMA;
D O I
10.1016/j.radonc.2009.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:654 / 654
页数:1
相关论文
共 50 条
  • [31] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    De Felice, Francesca
    Vetrone, Luigia
    Bulzonetti, Nadia
    Caiazzo, Rossella
    Marampon, Francesco
    Musio, Daniela
    Tombolini, Vincenzo
    MEDICAL ONCOLOGY, 2019, 36 (08)
  • [32] Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer
    Han, James
    Zakeri, Kaveh
    Raab, Gabriel
    Hesse, Jennifer
    Shamseddine, Achraf
    Chen, Linda
    Yu, Yao
    Kang, Jung Julie
    McBride, Sean M. M.
    Riaz, Nadeem
    Tsai, C. Jillian
    Gelblum, Daphna
    Sherman, Eric J. J.
    Wong, Richard J. J.
    Michel, Loren
    Lee, Nancy Y. Y.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (09): : 2207 - 2216
  • [33] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    Francesca De Felice
    Luigia Vetrone
    Nadia Bulzonetti
    Rossella Caiazzo
    Francesco Marampon
    Daniela Musio
    Vincenzo Tombolini
    Medical Oncology, 2019, 36
  • [34] Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy
    Franceschini, Davide
    Paiar, Fabiola
    Saieva, Calogero
    Bonomo, Pierluigi
    Agresti, Benedetta
    Meattini, Icro
    Greto, Daniela
    Mangoni, Monica
    Meacci, Fiammetta
    Loi, Mauro
    Zei, Giacomo
    Livi, Lorenzo
    Biti, Giampaolo
    RADIOLOGIA MEDICA, 2016, 121 (03): : 229 - 237
  • [35] Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan
    Yasuda, Koichi
    Uchinami, Yusuke
    Kano, Satoshi
    Taguchi, Jun
    Kawakita, Daisuke
    Kitayama, Megumi
    Nishioka, Kentaro
    Mori, Takashi
    Koizumi, Fuki
    Fujii, Yuri
    Shimizu, Yasushi
    Kobashi, Keiji
    Yoshimoto, Seiichi
    Nibu, Ken-ichi
    Homma, Akihiro
    Aoyama, Hidefumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (03) : 241 - 247
  • [36] Alternating chemotherapy: Gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer
    Aguilar-Ponce, J. L.
    Granados-Garcia, M.
    Cruz Lopez, J. C.
    Maldonado-Magos, F.
    Alvarez-Avitia, M. A.
    Arrieta, O.
    Gonzalez-Ramirez, I.
    Lara-Cruz, G.
    Martinez-Juarez, I.
    Medina-Santillan, R.
    Castillo-Hernandez, C.
    De la Garza-Salazar, J.
    ORAL ONCOLOGY, 2013, 49 (03) : 249 - 254
  • [37] Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study
    Karasawa, Kumiko
    Matsumoto, Fumihiko
    Ito, Sin
    Oba, Sinichi
    Furuya, Tomohisa
    Hirowatari, Hisako
    Izawa, Hiromi
    Ito, Kana
    Sasai, Keisuke
    ANTICANCER RESEARCH, 2012, 32 (09) : 4013 - 4018
  • [38] Conventional vs concomitant boost radiotherapy with concurrent cisplatin in advanced head and neck cancer
    Meshram, Sushil Dashrath
    Kamble, Krishna M.
    Diwan, Ashok K.
    Mohobia, Vijay K.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) : 770 - 774
  • [39] Concomitant Weekly Cisplatin and Altered Fractionation Radiotherapy in Locally Advanced Head and Neck Cancer
    Newlin, Heather E.
    Amdur, Robert J.
    Riggs, Charles E.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Mendenhall, William M.
    CANCER, 2010, 116 (19) : 4533 - 4540
  • [40] Concurrent radiotherapy with carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma
    Saigal, Kunal
    Santos, Edgardo S.
    Tolbe, Khaled
    Kwon, Deukwoo
    Elsayyad, Nagy
    Abramowitz, Matthew C.
    Mandalia, Amar
    Samuels, Michael Andrew
    FRONTIERS IN ONCOLOGY, 2014, 4